Tg Theraps Drug Patent Portfolio
Tg Theraps owns 1 orange book drug protected by 8 US patents Given below is the list of Tg Theraps's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10414773 | Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations | 26 May, 2035 | Active |
| US10947244 | Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations | 26 May, 2035 | Active |
| US9969740 | Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations | 26 May, 2035 | Active |
| US10072013 | Selective PI3K delta inhibitors | 02 Jul, 2033 | Active |
| US10570142 | Selective PI3K delta inhibitors | 02 Jul, 2033 | Active |
| US10981919 | Selective PI3K delta inhibitors | 02 Jul, 2033 | Active |
| US9150579 | Selective PI3K delta inhibitors | 02 Jul, 2033 | Active |
| US9669033 | Selective PI3K delta inhibitors | 02 Jul, 2033 | Active |
Latest Legal Activities on Tg Theraps's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Tg Theraps.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| transaction for FDA Determination of Regulatory Review Period | 30 Jan, 2024 | US9669033 |
| transaction for FDA Determination of Regulatory Review Period | 30 Jan, 2024 | US10570142 |
| transaction for FDA Determination of Regulatory Review Period | 30 Jan, 2024 | US10072013 |
| transaction for FDA Determination of Regulatory Review Period | 30 Jan, 2024 | US9150579 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Jan, 2024 | US10570142 |
| Surcharge for late Payment, Small Entity | 08 Jan, 2024 | US10570142 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US10072013 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US9150579 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US9669033 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US10570142 |
|
Petition to Accept Late Payment of Maintenance Fee Payment Filed
Critical
| 22 Nov, 2023 | US9150579 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 22 Nov, 2023 | US9150579 |
| Surcharge, Petition to Accept Pymt After Exp, Unintentional. | 22 Nov, 2023 | US9150579 |
|
Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted
Critical
| 22 Nov, 2023 | US9150579 |
|
Petition Decision - Accept Late Payment of Maintenance Fees - Granted
Critical
| 22 Nov, 2023 | US9150579 |
Tg Theraps's Family Patents
Tg Theraps drugs have patent protection in a total of 33 countries. It's US patent count contributes only to 15.4% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Tg Theraps Drug List
Given below is the complete list of Tg Theraps's drugs and the patents protecting them.
1. Ukoniq
Ukoniq is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10414773 | Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations |
26 May, 2035
(10 years from now)
| Active |
| US10947244 | Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations |
26 May, 2035
(10 years from now)
| Active |
| US9969740 | Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations |
26 May, 2035
(10 years from now)
| Active |
| US10072013 | Selective PI3K delta inhibitors |
02 Jul, 2033
(8 years from now)
| Active |
| US10570142 | Selective PI3K delta inhibitors |
02 Jul, 2033
(8 years from now)
| Active |
| US10981919 | Selective PI3K delta inhibitors |
02 Jul, 2033
(8 years from now)
| Active |
| US9150579 | Selective PI3K delta inhibitors |
02 Jul, 2033
(8 years from now)
| Active |
| US9669033 | Selective PI3K delta inhibitors |
02 Jul, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ukoniq's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List